Literature DB >> 27467142

Crimean-Congo Hemorrhagic Fever Virus in Bulgaria and Turkey.

Marc Mertens1, Isolde Schuster1, Miriam A Sas1, Zati Vatansever2, Zdenek Hubalek3, Esin Güven4, Ahmet Deniz5, Georgi Georgiev6, Raiko Peshev7, Martin H Groschup1.   

Abstract

Infections of humans with the tick-borne Crimean-Congo hemorrhagic fever virus (CCHFV) can cause a severe hemorrhagic fever with case fatality rates of up to 80%. Most humans are infected by tick bite, crushing infected ticks by hand or by unprotected contact with blood of viremic mammals. Next to the notified human CCHF cases, the real distribution and the situation in animals in Southeastern Europe are nearly unknown. Since domestic ruminants play a crucial role in the life cycle of the vector ticks and the transmission and amplification of the virus, the antibody prevalence in those animals is a good indicator for the presence of CCHFV in a region. Therefore, the prevalence of CCHFV-specific antibodies was investigated in domestic ruminants of different regions of Bulgaria and Turkey. Sera of 1165 ruminants were tested and a prevalence of up to 90% was identified. The overall prevalence for Bulgaria was 26% and for Turkey 57%. The results highlight the risk of human infections in those regions and the importance of the investigation of the prevalence in animals for identification of risk areas. This article provides a unique overview about published CCHFV antibody prevalence in animals in comparison to human incidences in different areas of Bulgaria and Turkey. Although it will help to complete the understanding of the CCHFV situation in these countries, it also demonstrates the lack of unpublished and published data even in these highly endemic areas.

Entities:  

Keywords:  Crimean–Congo hemorrhagic fever virus: CCHFV; ELISA; domestic animals; epidemiology

Mesh:

Substances:

Year:  2016        PMID: 27467142     DOI: 10.1089/vbz.2016.1944

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  5 in total

Review 1.  An Emerging Biothreat: Crimean-Congo Hemorrhagic Fever Virus in Southern and Western Asia.

Authors:  Paul W Blair; Jens H Kuhn; David B Pecor; Dmitry A Apanaskevich; Mark G Kortepeter; Anthony P Cardile; Aileen Polanco Ramos; Maryam Keshtkar-Jahromi
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

2.  Transmission dynamics and vaccination strategies for Crimean-Congo haemorrhagic fever virus in Afghanistan: A modelling study.

Authors:  Juan F Vesga; Madeleine H A Clark; Edris Ayazi; Andrea Apolloni; Toby Leslie; W John Edmunds; Raphaёlle Métras
Journal:  PLoS Negl Trop Dis       Date:  2022-05-23

3.  High seroprevalence for Crimean-Congo haemorrhagic fever virus in ruminants in the absence of reported human cases in many regions of Bulgaria.

Authors:  Iva Christova; Elitsa Panayotova; Martin H Groschup; Iva Trifonova; Simona Tchakarova; Miriam Andrada Sas
Journal:  Exp Appl Acarol       Date:  2018-04-30       Impact factor: 2.132

Review 4.  Surveillance of Arthropod-Borne Viruses and Their Vectors in the Mediterranean and Black Sea Regions Within the MediLabSecure Network.

Authors:  Anna-Bella Failloux; Ali Bouattour; Chafika Faraj; Filiz Gunay; Nabil Haddad; Zoubir Harrat; Elizabeta Jancheska; Khalil Kanani; Mohamed Amin Kenawy; Majlinda Kota; Igor Pajovic; Lusine Paronyan; Dusan Petric; Mhammed Sarih; Samir Sawalha; Taher Shaibi; Kurtesh Sherifi; Tatiana Sulesco; Enkelejda Velo; Lobna Gaayeb; Kathleen Victoir; Vincent Robert
Journal:  Curr Trop Med Rep       Date:  2017-03-17

5.  Broad-Range Antiviral Activity of Hydrogen Sulfide Against Highly Pathogenic RNA Viruses.

Authors:  Nikolay Bazhanov; Olivier Escaffre; Alexander N Freiberg; Roberto P Garofalo; Antonella Casola
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.